NEUBERGER BERMAN GROUP LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1465109
NEW YORK, NY
Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$37,071,501
+$22,163,620 QoQ
Shares Held
302,427
+113.8% QoQ
Ownership
0.467%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#36
of 343 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $1,452,567,393 across 97 Biotechnology names. PTGX ranks #11 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
559,445 | $277,893,114 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
421,976 | $263,118,914 | |
| 3 | TECH |
BIO-TECHNE Corp
|
2,844,692 | $200,977,489 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
248,355 | $78,502,531 | |
| 5 | CAI |
Caris Life Sciences, Inc.
|
3,590,963 | $63,990,960 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
633,533 | $50,232,830 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
552,158 | $41,124,727 | |
| 8 | INSM |
INSMED Inc
|
378,816 | $40,389,361 |
All Filings in PTGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,071,501 | 302,427 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $14,907,881 | 141,441 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,600,631 | 98,473 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,195,933 | 123,377 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,172,277 | 93,582 | Shares | Defined | 2025-08-25 | |
| No filing history on record for this holder in this stock. | ||||||